Cure My Disease

Don't miss your cure!

Home News Browse Soon ready About
Log in / Sign up
← Back to home

R1 Therapeutics

Clinical trials sponsored by R1 Therapeutics, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

  • New pill could help dialysis patients control dangerous phosphate levels Results expected Feb 2027 (estimated)
Browse trials soon ready across all sponsors →
Trials to join now! 1
Sort by
  • New pill could help dialysis patients control dangerous phosphate levels

    Disease control Recruiting now

    This study tests a new drug called AP306 in 168 adults on maintenance hemodialysis who have high phosphate levels (hyperphosphatemia). Participants take one of several fixed doses of AP306 or a placebo daily for 8 weeks. The main goal is to see if AP306 safely lowers blood phosph…

    Phase 2 • Sponsor: R1 Therapeutics • Aim: Disease control

    Last updated Aug 28, 2026 00:00 UTC

Cure My Disease

Helping patients find clinical trials that match their disease.

Why was Cure my disease built?

Explore

Home News Browse Glossary About Terms of use Contact us

This is a site from Cyber and Space